{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:43:18Z","timestamp":1786718598215,"version":"build-2736575974"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Niger J Clin Pract"],"published-print":{"date-parts":[[2017]]},"DOI":"10.4103\/njcp.njcp_20_17","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T03:48:42Z","timestamp":1512013722000},"page":"1350","source":"Crossref","is-referenced-by-count":1,"title":["Automated (Centrifugal) therapeutic plasma exchange option for guillain-barre syndrome: A report from Calabar, Nigeria"],"prefix":"10.4103","volume":"20","author":[{"given":"OE","family":"Iheanacho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Chimeziem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BS","family":"Sachais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PA","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1119-3077.219508-1","first-page":"939","article-title":"Clinical features, pathogenesis, and treatment of Guillain-Barr\u00e9 syndrome","author":"van","year":"2008","journal-title":"Lancet Neurol"},{"key":"key-10.4103\/1119-3077.219508-2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000184748","article-title":"The epidemiology of Guillain-Barr\u00e9 syndrome worldwide.A systematic literature review","author":"McGrogan","year":"2009","journal-title":"Neuroepidemiology"},{"key":"key-10.4103\/1119-3077.219508-3","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1086\/513795","article-title":"Mechanisms of Schwann cell damage in inflammatory neuropathy","author":"Koski","year":"1997","journal-title":"J Infect Dis"},{"key":"key-10.4103\/1119-3077.219508-4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: Immunotherapy for Guillain-Barr\u00e9 syndrome: Report of the Quality Standards Subcommittee of the American Academy of Neurology","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"key-10.4103\/1119-3077.219508-5","first-page":"Doc16","article-title":"Guillain-Barr\u00e9 syndrome: Clinical profile and management","author":"Sudulagunta","year":"2015","journal-title":"Ger Med Sci"},{"key":"key-10.4103\/1119-3077.219508-6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/1472-6963-11-101","article-title":"Cost-minimization analysis of the direct costs of TPE and IVIg in the treatment of Guillain-Barr\u00e9 syndrome","author":"Winters","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"key-10.4103\/1119-3077.219508-7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2183\/pjab.88.299","article-title":"Guillain-Barr\u00e9 syndrome and anti-ganglioside antibodies: A clinician-scientist's journey","author":"Yuki","year":"2012","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"key-10.4103\/1119-3077.219508-8","first-page":"149","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: The seventh special issue","author":"Schwartz","year":"2016","journal-title":"J Clin Apher"},{"key":"key-10.4103\/1119-3077.219508-9","first-page":"87","article-title":"Partial exchange blood transfusion as a treatment option for Guillain-Barre syndrome in resource-poor settings: A case report","author":"Lagunju","year":"2007","journal-title":"Afr J Neurol Sci"},{"key":"key-10.4103\/1119-3077.219508-10","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1586\/ern.09.81","article-title":"Plasmapheresis for neurological disorders","author":"Schr\u00f6der","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"key-10.4103\/1119-3077.219508-11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/jca.21262","article-title":"Filter membrane-based automated therapeutic plasma exchange: A report of two cases from Nigeria","author":"Arogundade","year":"2013","journal-title":"J Clin Apher"},{"key":"key-10.4103\/1119-3077.219508-12","first-page":"162","article-title":"Benefit of modified plasmapheresis in the management of myasthenia gravis: A case report","author":"Talabi","year":"2006","journal-title":"Niger J Med","ISSN":"https:\/\/id.crossref.org\/issn\/1115-2613","issn-type":"print"},{"key":"key-10.4103\/1119-3077.219508-13","unstructured":"Winters JL, Crookston KP, Eder AF, King KE, Kiss JE, McLeod BC, et al., editors. Therapeutic Apheresis: A Physician's Handbook. 2nd ed. Bethesda, Maryland: AABB Press; 2008. p. 1-40."},{"key":"key-10.4103\/1119-3077.219508-14","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jocn.2008.08.033","article-title":"Guillain-Barr\u00e9 syndrome: An update","author":"Vucic","year":"2009","journal-title":"J Clin Neurosci"},{"key":"key-10.4103\/1119-3077.219508-15","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1744-9987.2005.00319.x","article-title":"Complications of therapeutic plasma exchange: Experience with 4857 treatments","author":"Basic-Jukic","year":"2005","journal-title":"Ther Apher Dial"},{"key":"key-10.4103\/1119-3077.219508-16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/jca.20143","article-title":"Complications of therapeutic plasma exchange: A prospective study of 1,727 procedures","author":"Shemin","year":"2007","journal-title":"J Clin Apher"},{"key":"key-10.4103\/1119-3077.219508-17","first-page":"77","article-title":"First successful automated red cell exchange (Erythrocytapheresis) in Nigeria for a sickle cell anaemia patient with priapism: A case report","author":"Bazuaye","year":"2015","journal-title":"Ann Biomed Sci"},{"key":"key-10.4103\/1119-3077.219508-18","first-page":"557","article-title":"Plasma exchange in Canada.The Canadian Apheresis Study Group","author":"Rock","year":"1990","journal-title":"CMAJ"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:37:09Z","timestamp":1786714629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_20_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":18,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017]]}},"alternative-id":["219508"],"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_20_17","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}